Home » Newsletters » BioWorld Science

BioWorld Science

May 16, 2013

View Archived Issues

Mirabegron/solifenacin as an effective therapeutic option for overactive bladder

Imanova presents novel imaging tracer candidates

NIHR collaborates with companies on Alzheimer disease biomarker discovery

One-step generation of transgenic mice with multiple mutations

Vectura establishes strategic partnership in China for new respiratory business

The discovery of an antimicrobial adjuvant for sensitizing multidrug-resistant bacteria

Takeda Pharmaceutical presents highlights of fiscal 2012

New phase III study evaluates Stivarga in advanced hepatocellular carcinoma

Two new trials under way in sarilumab phase III program

OncoMed's anti-Notch 2/3 antibody OMP-59R5 begins study in SCLC

Herbal cream safely and effectively relieves symptoms of psoriasis

NP-260 shows efficacy in animal models of neuropathic pain

Soligenix begins phase I study of SGX-203 in pediatric Crohn's disease

Ultragenyx to conduct phase I/II trial of UX-003 for MPS VII

Elixir Medical receives CE mark approval for the DESolve Scaffold System

Ono Pharmaceutical updates developments of fourth quarter 2012

TaiGen seeks approval for oral formulation of nemonoxacin in Taiwan and China

Sanofi discloses novel PKC-beta inhibitors

Merck & Co. patents novel OX2 receptor antagonists

Chinese group presents new DGAT1 inhibitors

Researchers at Torrent Pharmaceuticals synthesize new TGR5 agonists

NewVac patents novel A2A receptor antagonists

Janssen obtains FDA approval for use of Simponi in new indication

FDA approves Xofigo in treatment of CRPC with bone metastases

XBiotech reports results on use of Xilonix in treatment-refractory NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.